- Home
- NXL vs SFHG Comparison
NXL vs SFHG Comparison
Compare NXL & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- SFHG
- Stock Information
- Founded
- NXL 2010
- SFHG 1993
- Country
- NXL United States
- SFHG Hong Kong
- Employees
- NXL N/A
- SFHG N/A
- Industry
- NXL Medical Specialities
- SFHG Publishing
- Sector
- NXL Health Care
- SFHG Consumer Discretionary
- Exchange
- NXL Nasdaq
- SFHG Nasdaq
- Market Cap
- NXL 17.8M
- SFHG 14.9M
- IPO Year
- NXL 2022
- SFHG 2024
- Fundamental
- Price
- NXL $0.93
- SFHG $0.67
- Analyst Decision
- NXL Strong Buy
- SFHG
- Analyst Count
- NXL 1
- SFHG 0
- Target Price
- NXL $5.00
- SFHG N/A
- AVG Volume (30 Days)
- NXL 191.8K
- SFHG 71.2K
- Earning Date
- NXL 11-07-2025
- SFHG 04-16-2025
- Dividend Yield
- NXL N/A
- SFHG N/A
- EPS Growth
- NXL N/A
- SFHG N/A
- EPS
- NXL N/A
- SFHG N/A
- Revenue
- NXL $174,813.00
- SFHG $19,760,935.00
- Revenue This Year
- NXL $38.28
- SFHG N/A
- Revenue Next Year
- NXL $185.71
- SFHG N/A
- P/E Ratio
- NXL N/A
- SFHG N/A
- Revenue Growth
- NXL 16.42
- SFHG 30.89
- 52 Week Low
- NXL $0.59
- SFHG $0.55
- 52 Week High
- NXL $4.49
- SFHG $24.00
- Technical
- Relative Strength Index (RSI)
- NXL 52.06
- SFHG 38.52
- Support Level
- NXL $0.86
- SFHG $0.66
- Resistance Level
- NXL $0.97
- SFHG $0.73
- Average True Range (ATR)
- NXL 0.08
- SFHG 0.04
- MACD
- NXL 0.00
- SFHG -0.00
- Stochastic Oscillator
- NXL 48.80
- SFHG 11.22
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.